BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 11109183)

  • 1. The influences of drug companies' advertising programs on physicians.
    Güldal D; Semin S
    Int J Health Serv; 2000; 30(3):585-95. PubMed ID: 11109183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumers' reports on the health effects of direct-to-consumer drug advertising.
    Weissman JS; Blumenthal D; Silk AJ; Zapert K; Newman M; Leitman R
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-82-95. PubMed ID: 14527237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
    Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
    CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of german physicians in private practice about contacts with pharmaceutical sales representatives.
    Lieb K; Brandtönies S
    Dtsch Arztebl Int; 2010 Jun; 107(22):392-8. PubMed ID: 20574555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.
    Fadare JO; Oshikoya KA; Ogunleye OO; Desalu OO; Ferrario A; Enwere OO; Adeoti A; Sunmonu TA; Massele A; Baker A; Godman B
    Hosp Pract (1995); 2018 Apr; 46(2):77-87. PubMed ID: 29426263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What patients think about promotional activities of pharmaceutical companies in Turkey.
    Semin S; Güldal D; Ozçakar N; Mevsim V
    Pharm World Sci; 2006 Aug; 28(4):199-206. PubMed ID: 17066242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescriber profiles.
    Capozzi JD; Rhodes R
    J Bone Joint Surg Am; 2001 Jul; 83(7):1115-6. PubMed ID: 11451989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' attitudes about gifts to physicians from pharmaceutical companies.
    Blake RL; Early EK
    J Am Board Fam Pract; 1995; 8(6):457-64. PubMed ID: 8585404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quest of prescribing practice in Pakistan.
    Shiwani MH
    J Pak Med Assoc; 2006 May; 56(5):249-50. PubMed ID: 16767958
    [No Abstract]   [Full Text] [Related]  

  • 12. An innovative approach to educating medical students about pharmaceutical promotion.
    Wilkes MS; Hoffman JR
    Acad Med; 2001 Dec; 76(12):1271-7. PubMed ID: 11739058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pharmaceutical promotion on prescribers in Jordan.
    Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
    Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pharmaceutical sales representatives on physician antibiotic prescribing.
    Cleary JD
    J Pharm Technol; 1992; 8(1):27-9. PubMed ID: 10118197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doctors and detailers: therapeutic education or pharmaceutical promotion?
    Lexchin J
    Int J Health Serv; 1989; 19(4):663-79. PubMed ID: 2583883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
    Datta A; Dave D
    Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
    McCarthy M
    BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey.
    Vancelik S; Beyhun NE; Acemoglu H; Calikoglu O
    BMC Public Health; 2007 Jun; 7():122. PubMed ID: 17592644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pills that ate your profits.
    Meyer H
    Hosp Health Netw; 1998 Feb; 72(3):18-22. PubMed ID: 9483145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug promotional practices in Mumbai: a qualitative study.
    Roy N; Madhiwalla N; Pai SA
    Indian J Med Ethics; 2007; 4(2):57-61. PubMed ID: 18630221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.